Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
QURE
#1637
uniQure N.V. - Ordinary Shares
48.7
2
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.69%
Monthly Change
+16.86%
6 month change
+430.14%
Year Change
+199.26%
Previous Close
49.5
6
Open
48.7
2
Low
48.7
2
High
48.7
2
Volume
76
Markets
US Stock Market
Healthcare
Biotechnology
QURE
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Current report, Q3 FY2024
2024.07.09
Uniqure N.V. current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
2024.08.01
Uniqure N.V. quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
2024.07.01
Uniqure N.V. current report, Q2 FY2024
8-K
Current report, Q2 FY2024
2024.06.20
Uniqure N.V. current report, Q2 FY2024
8-K
1
2
3
4
5
News
Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?
THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade) (NYSE:THQ)
Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes (NDX)
QURE Q2 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y
uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
Bristol Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
3 Biotech Stocks to Watch Before Wall Street Catches On
uniQure (QURE) Now Trades Above Golden Cross: Time to Buy?
Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing